PL413909A1 - Sposób detekcji i selekcji komórek hybrydomalnych produkujących pożądane przeciwciała - Google Patents

Sposób detekcji i selekcji komórek hybrydomalnych produkujących pożądane przeciwciała

Info

Publication number
PL413909A1
PL413909A1 PL413909A PL41390915A PL413909A1 PL 413909 A1 PL413909 A1 PL 413909A1 PL 413909 A PL413909 A PL 413909A PL 41390915 A PL41390915 A PL 41390915A PL 413909 A1 PL413909 A1 PL 413909A1
Authority
PL
Poland
Prior art keywords
hybridoma cells
cells producing
detection
selection
antibodies
Prior art date
Application number
PL413909A
Other languages
English (en)
Inventor
Tomasz Lipiński
Michał Skowicki
Artur Bednarkiewicz
Original Assignee
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością filed Critical Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL413909A priority Critical patent/PL413909A1/pl
Priority to PCT/PL2016/050037 priority patent/WO2017048146A1/en
Priority to US15/759,822 priority patent/US20180266956A1/en
Priority to EP16846943.5A priority patent/EP3350324A4/en
Publication of PL413909A1 publication Critical patent/PL413909A1/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • C12N5/163Animal cells one of the fusion partners being a B or a T lymphocyte
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2529/00Culture process characterised by the use of electromagnetic stimulation
    • C12N2529/10Stimulation by light
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G01N2021/6441Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6456Spatial resolved fluorescence measurements; Imaging
    • G01N21/6458Fluorescence microscopy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6489Photoluminescence of semiconductors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Przedmiotem wynalazku jest sposób detekcji i selekcji komórek hybrydomalnych produkujących pożądane przeciwciała, obejmujący umieszczanie komórek hybrydomalnych w naczyniu hodowlanym z biofunkcjonalizowaną powierzchnią, zawierającym medium hodowlane, dodawanie biofunkcjonalizowanych znaczników luminescencyjnych i poddanie hodowli komórek hybrydomalnych inkubacji, optyczne wykrywanie komórek hybrydomalnych produkujących pożądane przeciwciała poprzez reakcję biofunkcjonalizowanego znacznika luminescencyjnego z przeciwciałami i wykrycie otoczki sygnału ze znaczników luminescencyjnych wokół komórek hybrydomalnych produkujących pożądane przeciwciała, oddzielanie in situ komórek hybrydomalnych produkujących dany typ przeciwciała od pozostałych komórek.
PL413909A 2015-09-15 2015-09-15 Sposób detekcji i selekcji komórek hybrydomalnych produkujących pożądane przeciwciała PL413909A1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL413909A PL413909A1 (pl) 2015-09-15 2015-09-15 Sposób detekcji i selekcji komórek hybrydomalnych produkujących pożądane przeciwciała
PCT/PL2016/050037 WO2017048146A1 (en) 2015-09-15 2016-09-13 A method for detection and selection of hybridoma cells producing the desired antibodies
US15/759,822 US20180266956A1 (en) 2015-09-15 2016-09-13 A method for detection and selection of hybridoma cells producing the desired antibodies
EP16846943.5A EP3350324A4 (en) 2015-09-15 2016-09-13 PROCESS FOR DETECTION AND SELECTION OF HYBRIDOMA CELLS FOR THE PRODUCTION OF THE DESIRED ANTIBODIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL413909A PL413909A1 (pl) 2015-09-15 2015-09-15 Sposób detekcji i selekcji komórek hybrydomalnych produkujących pożądane przeciwciała

Publications (1)

Publication Number Publication Date
PL413909A1 true PL413909A1 (pl) 2017-03-27

Family

ID=58289526

Family Applications (1)

Application Number Title Priority Date Filing Date
PL413909A PL413909A1 (pl) 2015-09-15 2015-09-15 Sposób detekcji i selekcji komórek hybrydomalnych produkujących pożądane przeciwciała

Country Status (4)

Country Link
US (1) US20180266956A1 (pl)
EP (1) EP3350324A4 (pl)
PL (1) PL413909A1 (pl)
WO (1) WO2017048146A1 (pl)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900933A (en) * 1986-09-08 1990-02-13 C. R. Bard, Inc. Excitation and detection apparatus for remote sensor connected by optical fiber
US5674698A (en) * 1992-09-14 1997-10-07 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
AU2002253981B2 (en) 2001-02-20 2008-02-21 Abeome Corporation Rapid production of monoclonal antibodies
US7425426B2 (en) * 2004-03-15 2008-09-16 Cyntellect, Inc. Methods for purification of cells based on product secretion
WO2006021959A2 (en) 2004-08-25 2006-03-02 Seng Enterprises Ltd. Method and device for isolating cells
US20070243573A1 (en) 2006-02-14 2007-10-18 Kimio Sumaru Method and apparatus for immobilizing cells, and cell-immobilized substrate
JP4148367B1 (ja) 2007-08-02 2008-09-10 富山県 細胞のスクリーニング方法
WO2012156432A1 (en) * 2011-05-17 2012-11-22 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Device and probe for detection of infection
JP5998217B2 (ja) * 2012-07-06 2016-09-28 株式会社日立ハイテクノロジーズ 分析装置及び分析方法

Also Published As

Publication number Publication date
EP3350324A1 (en) 2018-07-25
US20180266956A1 (en) 2018-09-20
WO2017048146A1 (en) 2017-03-23
EP3350324A4 (en) 2019-03-20

Similar Documents

Publication Publication Date Title
EA201992670A1 (ru) Способ получения биспецифических антител, биспецифические антитела и терапевтическое применение таких антител
ZA201703241B (en) Anti-c5 antibodies and methods of use
AR096839A1 (es) Proceso mejorado para la producción de anticuerpos monoclonales
SA518391704B1 (ar) C5 أجسام مضادة لـ وطرق لاستخدامها
PH12018502354B1 (en) Anti-c5 antibodies and methods of use
PL439808A1 (pl) Sposoby i kompozycje hodowli komórkowych do produkcji przeciwciał
CL2019002521A1 (es) Método para producir anticuerpos multiespecíficos.
EA202091422A1 (ru) Способ непрерывного производства продуктов на основе биспецифических антител
MX2015008754A (es) Caracterizacion de un medicamento relacionado con acetato de glatiramer.
WO2016091888A3 (en) Methods, kits and compositions for phenotyping pancreatic ductal adenocarcinoma behaviour by transcriptomics
MX347320B (es) Anticuerpo bloqueador de agr2 y uso del mismo.
MX2019005476A (es) Ensayo de celulas madre pluripotentes.
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
EA202090766A1 (ru) Крупномасштабное производство жидких и твердых продуктов на основе trichoderma
PE20220004A1 (es) Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh
EP3868863A4 (en) CELL CULTURE SUBSTRATE, METHOD FOR PREPARING A CELL CULTURE SUBSTRATE, AND METHOD FOR PREPARING SPHEROIDS
PL413909A1 (pl) Sposób detekcji i selekcji komórek hybrydomalnych produkujących pożądane przeciwciała
MY192147A (en) Method for obtaining high-yield, stable expression cell clones and antibody molecules obtained thereby
EA202190265A1 (ru) Способ получения t-клеток
AR119269A1 (es) Métodos y composiciones de cultivo celular para producción de anticuerpos
MY188404A (en) Stem cell culturing method
UA107713U (uk) Спосіб отримання імунного електрохімічного біосенсора для реєстрації антигенів патогенних мікроорганізмів
TH166463A (th) มีเดียมปราศจาก-ซีรัมที่มี pdgf สำหรับ ds เซลล์